<DOC>
	<DOCNO>NCT00857090</DOCNO>
	<brief_summary>The objective study assess systemic exposure , safety efficacy three concentration OMS201 subject undergoing retrograde ureteroscopic removal upper urinary tract stone .</brief_summary>
	<brief_title>Pharmacokinetic , Safety Efficacy Study OMS201 Subjects Undergoing Retrograde Ureteroscopic Removal Upper Urinary Tract Stones</brief_title>
	<detailed_description>The main objective estimate systemic exposure OMS201 retrograde ureteroscopic treatment upper urinary tract stone . Safety assess vital sign , laboratory value adverse event . Exploratory efficacy measure assess effect OMS201 postoperative pain , duration surgery ease placement ureteral access sheath .</detailed_description>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Urinary Calculi</mesh_term>
	<mesh_term>Urolithiasis</mesh_term>
	<criteria>18 65 year age . Subject undergoing retrograde ureteroscopic removal renalcollecting system ureteral stone general anesthesia use . No allergy individual ingredient OMS201 . Subject take prohibited medication . Pregnant woman , nurse mother , woman childbearing age unwilling take contraception duration study . Subject renal transplant , single kidney , compromise renal function , evidence papillary necrosis . Subject evidence clinically significant urinary tract infection . Subject prior history open laparoscopic urinary tract surgery , history ureteral stricture . Subject congenital anomaly would engender increased procedural safety risk . Subject history clinically significant chronic episodic hypotension . Subject 's physical examination significantly abnormal purpose study determine Investigator . Subject 's screen laboratory evaluation within normal limit AND abnormal result determine Investigator clinically significant . Subject risk anesthesia . Subject chronic diuretic use . Subject present condition history clinically significant medical disorder determine Investigator unsuitable candidate receipt investigational drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Urinary Calculi</keyword>
	<keyword>Urinary Stones</keyword>
	<keyword>Urinary Tract Stones</keyword>
	<keyword>Renal Calculi</keyword>
	<keyword>Kidney Stones</keyword>
	<keyword>Calculi</keyword>
	<keyword>Urolithotomy</keyword>
	<keyword>Ureteroscopy</keyword>
</DOC>